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Research
AbstrACt
Objectives Research has demonstrated that the 
association between high blood pressure and outcomes is 
attenuated among older adults with functional limitations, 
compared with healthier elders. However, it is not known 
whether these patterns vary by racial/ethnic group. 
We evaluated race/ethnicity-specific patterns of effect 
modification in the association between blood pressure 
and incident cardiovascular disease (CVD) by functional 
status.
setting We used data from the Multi-Ethnic Study of 
Atherosclerosis (2002–2004, with an average of 8.8 
years of follow-up for incident CVD). We assessed effect 
modification of systolic blood pressure and cardiovascular 
outcomes by self-reported physical limitations and by 
age.
Participants The study included 6117 participants (aged 
46 to 87; 40% white, 27% black, 22% Hispanic and 
12% Chinese) who did not have CVD at the second study 
examination (when self-reported physical limitations were 
assessed).
Outcome measures Incident CVD was defined as an 
incident myocardial infarction, coronary revascularisation, 
resuscitated cardiac arrest, angina, stroke (fatal or non-
fatal) or death from CVD.
results We observed weaker associations between 
systolic blood pressure (SBP) and CVD among white adults 
with physical limitations (incident rate ratio (IRR) per 
10 mm Hg higher SBP: 1.09 (95% CI 0.99 to 1.20)) than 
those without physical limitations (IRR 1.29 (1.19, 1.40); 
P value for interaction <0.01). We found a similar pattern 
among black adults. Poor precision among the estimates 
for Hispanic or Chinese participants limited the findings in 
these groups. The attenuated associations were consistent 
across both multiplicative and additive scales, though 
physical limitations showed clearer patterns than age on 
an additive scale.
Conclusion Attenuated associations between high blood 
pressure and incident CVD were observed for blacks 
and whites with poor function, though small sample 
sizes remain a limitation for identifying differences 
among Hispanic or Chinese participants. Identifying the 
characteristics that distinguish those in whom higher 
SBP is associated with less risk of morbidity or mortality 
may inform our understanding of the consequences of 
hypertension among older adults.
IntrOduCtIOn 
High blood pressure (systolic blood pres-
sure (SBP) ≥140 mm Hg or diastolic blood 
pressure (DBP) ≥90 mm Hg or taking anti-
hypertensive medicine) is a major cause of 
morbidity and mortality among American 
adults, and is responsible for an estimated 
US$48.6 billion in direct and indirect costs 
per year.1 However, the health risks associated 
with high blood pressure are not uniform in 
all adults; some subgroups have been iden-
tified in which elevated blood pressure is 
not associated with increased morbidity or 
mortality. For example, among older adults 
with poor functional status, measured by slow 
gait speed2 3 or by functional limitations, the 
association between high blood pressure and 
mortality is attenuated compared with elders 
with better functional status.4 Interestingly, 
strengths and limitations of this study
 ► The Multi-Ethnic Study of Atherosclerosis is the 
largest cohort of middle-aged and older adults in 
the USA from four racial/ethnic groups (white, black, 
Hispanic and Chinese).
 ► We evaluated self-reported physical limitations 
(based on two questions) and chronological age as 
potential effect modifiers of systolic blood pressure 
(SBP) and cardiovascular outcomes.
 ► Small sample size among some racial/ethnic groups 
limited the precision of our estimates.
 ► Additional research is needed to investigate 
heterogeneity in associations between SBP and 
cardiovascular disease among racial/ethnic minority 
populations, and to understand the underlying 
biological mechanisms.
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in this latter study, the effect modification of blood pres-
sure and mortality by functional status was less apparent 
in middle-aged participants.4 There are limited data on 
functional status as an effect modifier of blood pressure 
and cardiovascular outcomes; existing studies have been 
limited to older adults.5 6 Thus, it is not yet clear how age 
and functional limitations pattern risks of cardiovascular 
disease (CVD) associated with elevated SBP.
Additionally, it is plausible that the patterns of blood 
pressure, functional status and morbidity vary by racial/
ethnic group. Previous research has demonstrated 
patterns of attenuation in populations of Latinos2 and 
populations of white Americans and African Americans.4 5 
Race/ethnicity, as a proxy for biological characteristics as 
well as lifelong contextual influences, cultural norms and 
cumulative stressors,7 is associated with blood pressure 
levels and with rates of CVD. For example, a 10 mm Hg 
higher SPB level is associated with a larger increase in 
stroke risk for blacks than for whites.8 Our objective was 
to explore racial/ethnic heterogeneity in the interaction 
of blood pressure and functional status on incident CVD.
MethOds
study population
We used data from the Multi-Ethnic Study of Atheroscle-
rosis (MESA) to explore race/ethnicity-specific patterns 
of effect modification in the association between blood 
pressure and incident CVD by physical limitations and by 
age.
MESA includes 6814 adults aged 45–84 who self-iden-
tified as white, black, Hispanic or Chinese from six areas 
across the USA (New York, New York; Baltimore, Mary-
land; Forsyth County, North Carolina; Chicago, Illinois; 
St Paul, Minnesota; and Los Angeles, California). White 
participants were recruited at all sites; black participants 
were recruited at all sites except for Minnesota. Hispanic 
participants came from New York, Minnesota and Cali-
fornia, and Chinese participants came from Chicago 
and California. Participants were excluded if they had a 
history of heart attack, angina, stroke or transient isch-
aemic attack, heart failure, resuscitated cardiac arrest or 
procedures related to CVD. Participants were followed 
from 2000–2002 until 2010–2012, with a total of five study 
examinations. Retention was 92.4% from the first exam-
ination to the second examination, and 75.7% from the 
fourth examination to the final examination.9 The partic-
ipants provided informed consent.10
exposure: sbP
Blood pressure was measured at each examination, 
following a standardised protocol. After 5 min of seated 
rest, SBP and DBP were measured three times, at 2 min 
intervals, using an automated oscillometric sphygmoma-
nometer.11 The average of the second and third measure-
ments was used for analysis. We used SBP measured at 
the second examination (2002–2004) as the primary 
exposure of interest because physical limitations were not 
assessed at the baseline examination.
effect modifiers
We used two effect modifiers for this analysis: self-reported 
physical limitations and age. Physical limitations were 
assessed at examination 2, in 2002–2004, and measured 
with two questions based off the same prompt: ‘During 
the past 4 weeks, have you had any of the following prob-
lems with your work or other regular daily activities as a 
result of your physical health?’ Participants were consid-
ered to have physical limitations if they answered ‘yes’ to 
either ‘You accomplished less than you would have liked 
to’ or ‘You were limited in the kind of work you do or 
other regular daily activities.’
As a secondary analysis, we used summary scores from a 
modified version of the 12-Item Short Form Health Survey 
(SF-12) (version 2)12 to measure overall physical health 
and well-being. The SF-12 survey is a shortened version 
of the SF-36 scale and has been validated in a variety of 
settings.13 14 The Physical Component Summary score 
(SF12-P) is a weighted average of questions about general 
health, limitations in moderate activities or climbing 
stairs, physical limitations, emotional limitations, pain 
interfering with work, feeling downhearted and blue 
and health interfering with social activities. SF12-P scores 
range from 0 to 100 (higher scores represent better func-
tion) and are standardised so that a score of 50 reflects 
the average of the general US population.15 The SF12-P 
scale was used as a secondary analysis because it includes 
the physical limitation questions described above, in 
addition to other covariates that were less related to the 
underlying construct of functional status.
Outcome: incident CVd
The outcome of interest was incident CVD, measured 
through the end of 2012. MESA participants were 
contacted by phone every 9 to 12 months and asked about 
interim cardiovascular events. Medical records, death 
certificates and next-of-kin interviews (for out-of-hospital 
cardiovascular deaths) were used by a team of two study 
cardiologists, cardiovascular epidemiologists or neurolo-
gists to determine the date of incident CVD.16 CVD was 
defined as an incident myocardial infarction, coronary 
revascularisation, resuscitated cardiac arrest, angina, 
stroke (fatal or non-fatal) or CVD death.17
Covariates
All covariates were measured at the second examination 
(2002–2004). Demographic confounders included age, 
sex and income. Income was dichotomised for this anal-
ysis at earning US$75 000 per year. Additional covariates 
included smoking (never, former or current smoker), 
body mass index (BMI), total cholesterol, diabetes 
status and medication use. Diabetes status was catego-
rised as normal, impaired fasting glucose or untreated 
diabetes and treated diabetes based on the 2003 Amer-
ican Diabetes Association fasting criteria algorithm. 
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Medications (antihypertensives and statins) were assessed 
by visual inspection of medication containers by study 
personnel or by self-report.
statistical methods
Participants with missing data on SBP or physical limita-
tions at examination 2, or on incident CVD status, were 
excluded, as were participants who had developed CVD 
by examination 2. We first stratified the study popula-
tion by race/ethnicity, and summarised blood pressure, 
functional status and other covariates within each racial/
ethnic group. Then we used Poisson models to estimate 
the incident rate ratios for incident CVD per 10 mm Hg 
higher SBP, using an offset for the person-time contrib-
uted until incident CVD, death or lost to follow-up. A 
likelihood ratio test provided evidence for a three-way 
interaction (on a multiplicative scale) between race/
ethnicity, age and SBP (P=0.07), so we present models 
stratified on race/ethnicity.
All models were adjusted for age (as a linear term), 
sex and income. We ran separate sets of models for each 
modifier of interest: self-reported physical limitations, age 
and SF12-P score. We checked for a three-way interaction 
between SBP, physical limitations and age (<65 vs >=65) in 
race-specific models, but did not find any evidence that 
the association between SBP and physical limitations on 
incident CVD varied by age category.
To assess modification on a multiplicative scale, we ran 
Poisson models stratified by functional status (eg, with 
physical limitations; without physical limitations; age <65; 
age ≥65) and by race/ethnicity to estimate the association 
between SBP (as a continuous measure) and CVD. We 
tested for interaction by running models with an inter-
action term between SBP and the measure of functional 
status. We explored the impact of adjusting for additional 
covariates (smoking, diabetes, antihypertensive medica-
tion, statins, total cholesterol, DBP and BMI) among white 
and black subgroups only, due to limited sample size. Due 
to conceptual concern over distinguishing confounders 
from mediators in the joint effects of SBP and functional 
status on CVD, we present the minimally adjusted models 
as our primary results.
We also explored the relationship between SBP and 
CVD by functional status on an additive scale, because 
departures from multiplicativity may result from different 
baseline levels of risk in the subgroups of interest. We ran 
Poisson models with SBP categorised into quintiles, in 
order to estimate the incidence rate of CVD at each quin-
tile. Models of physical limitation were stratified (with 
limitations vs without limitations) and adjusted for age. 
In the models for age, incidence rates were estimated at 
the first and third quartile (ages 54 and 70, respectively). 
We used multivariable regression spline models to eval-
uate the best shape (linear or non-linear) of the trend 
in incidence rate across quintiles. We calculated slopes 
across quintiles to represent the average incidence rate 
difference (IRD) per quintile. All analyses were done in 
Stata V.13.1.
results
Our analysis excluded 584 participants who did not have 
a blood pressure measurement at examination 2, 14 
participants who did not have physical function measures 
at examination 2, 5 participants with missing information 
on incident CVD and 3 participants who had prevalent 
CVD at examination 2. Excluded participants were older 
(mean age 67.9 vs 63.5), more likely to be male (61.2% 
vs 47.4%), less well educated (22.7% vs 36.7% with bach-
elor’s or higher), had lower incomes (2.0% vs 22.6% 
with income >US$75 000) and were more likely to report 
physical limitations (50.5% vs 27.3%). SBP, DBP and 
racial/ethnic distribution were similar among excluded 
and included participants. Among the analytic sample 
of 6117 participants, age at baseline ranged from 46 to 
87. Participants were followed for an average of 8.8 years 
(until time of CVD incidence, death, loss to follow-up or 
31 December 2012), during which time there were 557 
incident cases of CVD detected.
White participants were older, more educated and had 
higher income levels than members of other racial/ethnic 
groups (table 1). Black participants had the highest mean 
SBP and were most likely to be on antihypertensive medi-
cations. Black participants were most likely to report phys-
ical limitations, while white participants were most likely 
to be diagnosed with CVD during follow-up.
We observed a generally weaker association between 
SBP and CVD among low-functioning subgroups (those 
with physical limitations or over age 65) compared with 
high-functioning subgroups (table 2). This pattern was 
most apparent among white participants, though there 
was a similar pattern among black participants that did 
not reach statistical significance for the interaction of SBP 
and physical limitations. Among Hispanic and Chinese 
participants, the association between SBP and CVD 
appeared not to be modified by measures of functional 
status. Among all racial/ethnic groups, higher SBP was 
associated with higher incidence of CVD. There was no 
evidence for an interaction between SBP, age and phys-
ical limitation among white (P=0.71) or black (P=0.22) 
participants. Sample sizes were insufficient to estimate 
the three-way interaction among Hispanic or Chinese 
participants.
The estimated CVD incidence rates by quintile of SBP 
revealed more nuances about the race/ethnicity-spe-
cific associations between SBP, functional status and 
CVD (figure 1). Among all racial/ethnic groups, the 
incidence of CVD was higher among low-functioning 
subgroups (with physical limitations or older age) than 
high-functioning subgroups (without physical limitations 
or younger age). Multivariable spline regression models 
reported that a linear fit was appropriate for the associa-
tion between SBP and CVD in all subgroups.
Among white participants, the estimated increase in 
CVD per quintile higher SBP was smaller for those with 
physical limitations than for those without physical limita-
tions (IRD 1.67 vs 3.35 per 1000 person-years). However, 
the average IRD across quintiles of SBP was slightly larger 
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among older whites (estimated at age 70) compared with 
younger whites (estimated at age 54). Among black partic-
ipants, the association of SBP and CVD was weaker both 
among participants with physical limitations and among 
older participants, compared with those without physical 
limitations and younger participants. In contrast, among 
Hispanic participants, those with physical limitations and 
those of older age had larger IRDs (a larger increase in 
CVD incidence per quintile higher SBP) than those with 
no physical limitations and at younger ages, respectively. 
Large CIs limit generalisations among Chinese partici-
pants. Chinese participants were less likely to report phys-
ical limitations and less likely to develop CVD than other 
racial/ethnic groups, further hindering statistical power.
Adjustment for additional covariates resulted in gener-
ally attenuated but consistent results among white and 
black participants (figure 2). The adjusted association 
of SBP with CVD risk was statistically significant among 
those with high functional status, but approached unity 
in those with physical limitations or age ≥65.
Table 1 Characteristics of analytic sample at Multi-Ethnic Study of Atherosclerosis examination 2 by race/ethnicity
White Black Hispanic Chinese P value
N 2421 1659 1320 717
Age (years) 64.1 63.5 62.7 63.3 <0.001
Female 51.6% 54.9% 52.3% 51.3% 0.17
Income
  <US$16 000 10.0% 19.9% 38.6% 44.5%
  US$16 000–US$39 999 21.2% 32.0% 35.3% 22.4%
  US$40 000–US$74 999 30.9% 30.1% 18.6% 15.4%
  US$75 000+ 37.8% 18.0% 7.5% 17.7% <0.001
Education
  High school or less 21.1% 29.9% 63.7% 39.1%
  Some college or Associate’s 27.8% 35.2% 26.0% 20.3%
  Bachelor’s or more 51.1% 34.9% 10.3% 40.6% <0.001
BMI (kg/m2) 27.7 30.1 29.6 24.1 <0.001
Current smoker 10.9% 16.0% 10.2% 5.6% <0.001
Total cholesterol (mg/dL) 192.8 188.4 194.1 189.9 <0.001
Taking statins 23.5% 18.8% 16.6% 17.2% <0.001
Diabetes
  Impaired fasting glucose 17.9% 20.1% 21.7% 20.6%
  Treated diabetes 5.9% 16.6% 16.6% 11.2% <0.001
DBP (mm Hg) 68.9 73.5 70.1 69.3 <0.001
Taking antihypertension medication 37.8% 54.0% 37.3% 32.1% <0.001
SBP, mean 121.0 130.2 125.0 120.7 <0.001
SBP quintiles
  Quintile 1 (60–107 mm Hg) 24.3% 12.2% 20.7% 27.8%
  Quintile 2 (107.5–116.5 mm Hg) 23.3% 16.8% 20.2% 19.4%
  Quintile 3 (117–127 mm Hg) 19.2% 19.8% 18.7% 18.0%
  Quintile 4 (127.5–141 mm Hg) 19.0% 23.7% 20.0% 18.6%
  Quintile 5 (141.5–230 mm Hg) 14.2% 27.6% 20.5% 16.3% <0.001
Self-reported physical limitations 26.4% 31.7% 27.2% 20.8% <0.001
  Accomplished less than liked 23.1% 27.8% 24.6% 19.1%
  Limited in work or daily activities 17.2% 20.7% 21.8% 16.5%
SF12-P score 49.9 47.8 47.9 48.9 <0.001
Incident CVD 10.2% 8.9% 9.2% 5.7% <0.01
Mean time to CVD or end of follow-up 
(years)
8.9 8.6 8.7 9.0 <0.001
BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure; SF12-P, Physical 
Component Summary score. 
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Using SF12-P scores to measure functional status 
produced similar patterns to those in figure 1 but with 
smaller differences between low-functioning (estimated 
at SF12-P=44.5) and high-functioning (SF12-P=55.5) 
groups (see online supplementary appendix figure 1).
dIsCussIOn
Overall, we observed attenuated associations between 
SBP and incident CVD among those with low functional 
status (measured by self-reported physical limitations and 
by chronological age) among white and black adults. 
This pattern was generally consistent across both multi-
plicative and additive scales using self-reported physical 
limitations, but not age (as older white participants had 
a slightly larger increase in risk per quintile higher SBP 
than younger white participants). Our findings are consis-
tent with previous research that has found attenuated or 
inverted associations between blood pressure and health 
outcomes among low-functioning subgroups (defined 
by age, walking speed or limitations in activities of daily 
living).3 4 18
Blood pressure treatment guidelines and randomised 
controlled trials have frequently used age to define treat-
ment targets or populations of interest.19–22 Chronological 
age is an imprecise measure of functional status, though 
it is easily and routinely collected. Others have recognised 
the limitations of relying on chronological age to predict 
health-related outcomes.23 Among white participants, 
using self-reported physical limitations as a measure of 
functional status provided consistent evidence of attenu-
ated associations between SBP and incident CVD among 
adults with physical limitations across multiplicative and 
additive scales, while there was not an attenuated asso-
ciation between SBP and incident CVD among older 
Table 2 Estimated associations (incident rate ratio (IRR)* per 10 mm Hg higher systolic blood pressure (SBP) between SBP 
and incident cardiovascular disease (CVD) by measures of functional status and racial/ethnic group
No physical 
limitations With physical limitations Age <65 Age ≥65
Overall
  N 4446 1671 3218 2899
  IRR 1.21 1.10 1.30 1.11
  95% CI 1.16 to 1.27 1.03 to 1.17 1.22 to 1.39 1.06 to 1.17
  P value for interaction 0.04 <0.01
White
  N 1783 638 1229 1192
  IRR 1.29 1.09 1.33 1.17
  95% CI 1.19 to 1.40 0.99 to 1.20 1.18 to 1.49 1.01 to 1.07
  P value for interaction <0.01 <0.01
Black
  N 1134 525 864 795
  IRR 1.25 1.10 1.36 1.10
  95% CI 1.14 to 1.37 0.96 to 1.25 1.22 to 1.52 1.00 to 1.21
  P value for interaction 0.14 <0.01
Hispanic
  N 961 359 740 580
  IRR 1.11 1.10 1.13 1.08
  95% CI 1.00 to 1.23 0.95 to 1.27 0.97 to 1.31 0.98 to 1.19
  P value for interaction 0.89 0.66
Chinese
  N 568 149 385 332
  IRR 1.21 1.23 –† 1.10
  95% CI 1.01 to 1.44 0.95 to 1.58 –† 0.94 to 1.29
  P value for interaction 0.93 – 
*From Poisson models with offset for person-time contributed until incident CVD, death or loss to follow-up. Models for physical limitations 
were adjusted for age (continuous), gender and income (dichotomised at US$75 000. Models by age category were adjusted for gender and 
income (dichotomised at US$75,000).
†Omitted due to small number of events (<10).
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adults on an additive scale. Among blacks, both older age 
and physical limitations revealed attenuated associations 
between SBP and CVD on both multiplicative and addi-
tive scales (though not statistically significant for physical 
limitations on a multiplicative scale). Additionally, across 
all race/ethnic groups, those with physical limitations 
had higher incidence of CVD at all levels of SBP than 
those without physical limitations, after adjusting for age. 
Where feasible, self-reported physical limitations or other 
specific measures of functional status may be a useful 
addition to methods of assessing risk in clinical settings.
We observed no apparent patterning of SBP and CVD 
by functional status among Hispanics or Chinese partici-
pants. For Chinese participants, the small sample size is 
likely a key limitation for distinguishing patterns by func-
tional status. Additionally, Chinese participants were least 
likely to report physical limitations and had the lowest 
incidence of CVD. For Hispanic participants, associations 
Figure 1 Estimated incidence rates of cardiovascular disease by quintile of systolic blood pressure, by measures of functional 
status and race/ethnicity. PY, per 1000 person years.
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between SBP and CVD were similar by functional status on 
a multiplicative scale, and on an additive scale appeared to 
be stronger (larger average IRDs across quintiles of SBP) 
for those with physical limitations and those at higher 
ages than those without physical limitations and at lower 
ages, respectively. Hispanic participants were also the 
youngest of the racial/ethnic groups in MESA. Previous 
research in a Hispanic population found that the associa-
tion between SBP and all-cause mortality was attenuated 
among slow walkers compared with fast walkers; however, 
these participants were older (mean age 70.5 years) and 
less healthy overall (mean SBP 139 mm Hg, 22.8% on 
diabetes medication) than MESA’s Hispanic participants 
(mean age 62.7 years, mean SBP 125 mm Hg, 16.3% on 
diabetes medication). Future research should continue to 
investigate patterns of SBP and CVD risk among diverse 
minority populations.
Some limitations are important to consider. Self-re-
ported physical limitations, assessed by two questions, 
is a crude measure of functional status; more objective 
measures may demonstrate even better discrimination in 
CVD risk. Additionally, previous research has shown that 
the health risks of high SBP among those with functional 
impairments may be stronger among older adults than 
among middle-aged adults.4 We did not find any evidence 
that the association between SBP and physical limitations 
varied by age (<65 vs ≥65), though we may have been 
underpowered to detect heterogeneity statistically.
Additionally, more research is needed to inform how 
observed differences in CVD risk associated with SBP 
should influence treatment of high blood pressure. The 
biological mechanism mediating an attenuated associa-
tion between high blood pressure and outcomes among 
low-functioning older adults remains uncertain, although 
there are several plausible explanations. Poor physical 
functioning may be associated with compromised haemo-
dynamic regulation, vascular stiffening and insufficient 
cerebral, myocardial or renal perfusion, resulting in 
poorer health outcomes independent of SBP. Others have 
noted the challenges in accurate measurement of blood 
pressure in older adults, due to orthostatic hypotension, 
pseudohypertension and postprandial hypertension,24 
suggesting that attenuated association with outcomes 
may reflect measurement error. Another possibility is that 
treatment of high blood pressure, which often requires 
multiple medications, could result in polypharmacy or 
other adverse events such as falls and fractures,25 and 
these adverse events could initiate a cascade of events that 
could result in hospitalisation, morbidity and even death. 
Thus, observed low blood pressures may be correlated 
poorer outcomes. Our analysis shows that future studies 
that evaluate benefits of treating high blood pressure 
Figure 2 Forest plot of adjusted incident rate ratio for incident cardiovascular disease per 10 mm Hg higher systolic blood 
pressure (SBP) among white and black participants.
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should explore patterns by race/ethnicity as well as func-
tional status.
The presence of racial/ethnic variation in associations 
between SBP, incident CVD and functional status do not 
imply biologically predetermined differences in risks; 
rather, our findings should caution against generalising 
results from predominantly white study populations to 
other racial/ethnic populations. The observed differ-
ences that we found are likely the result of broad social 
and environmental influences throughout the life course 
that are strongly patterned by racial/ethnic identity in the 
USA. However, these findings are also novel and, if repli-
cated, much more research is needed to understand the 
causal pathways resulting in racial/ethnic heterogeneity 
in associations between SBP, functional status and CVD.
In summary, we found that the risk of incident CVD 
associated with high blood pressure appears to be atten-
uated among white and black adults with physical limita-
tions and at older ages in a diverse cohort of middle aged 
and older adults. Patterns among Hispanic and Chinese 
adults were less clear, which likely reflects limited sample 
sizes. Understanding how functional status (or factors 
underlying functional impairments) influence CVD risk 
across racial/ethnic groups could be useful for identi-
fying at-risk persons and informing public health strate-
gies to improve health and reduce CVD risk.
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